img

Global Prescription Dermatological Drugs Market Analysis 2016-2024 and Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 93 | Industry : Life & Medical

Publisher : 9 | Format : PDF

Global Prescription Dermatological Drugs Market Analysis 2016-2024 and Forecast 2024-2034

Snapshot

The global Prescription Dermatological Drugs market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Prescription Dermatological Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.)
Anti-acne Drugs 
Anti-aging Drugs 
Dermatitis Drugs 
Hair Loss Drugs 
Psoriasis Drugs 
Skin Cancer Drugs 
Melasma Drugs 
Seborrhea Drugs

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.)
Johnson & Johnson 
Merck 
Bayer 
Mylan Pharmaceuticals 
Pfizer 
F. Hoffmann-La Roche 
Allergan 
Valeant Pharmaceuticals 
PharmaDerm Pharmaceuticals 
Allergan Inamed Corporation 

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.)
Hospital Pharmacies 
Retail Pharmacies 
Online Pharmacies

Region Coverage (Regional Production, Demand & Forecast by Countries etc.)
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)

Table of Content

Table of Contents
Table of Contents
1 Industry Overview
1.1 Prescription Dermatological Drugs Industry
Figure Prescription Dermatological Drugs Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Prescription Dermatological Drugs
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Prescription Dermatological Drugs
1.2.2 Downstream
Table Application Segment of Prescription Dermatological Drugs
Table Global Prescription Dermatological Drugs Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Prescription Dermatological Drugs Market by Type
3.1 By Type
3.1.1 Anti-acne Drugs 
Table Major Company List of Anti-acne Drugs 
3.1.2 Anti-aging Drugs 
Table Major Company List of Anti-aging Drugs 
3.1.3 Dermatitis Drugs 
Table Major Company List of Dermatitis Drugs 
3.1.4 Hair Loss Drugs 
Table Major Company List of Hair Loss Drugs 
3.1.5 Psoriasis Drugs 
Table Major Company List of Psoriasis Drugs 
3.1.6 Skin Cancer Drugs 
Table Major Company List of Skin Cancer Drugs 
3.1.7 Melasma Drugs 
Table Major Company List of Melasma Drugs 
3.1.8 Seborrhea Drugs
Table Major Company List of Seborrhea Drugs
3.2 Market Size
Table Global Prescription Dermatological Drugs Market 2016-2020, by Type, in USD Million
Figure Global Prescription Dermatological Drugs Market Growth 2016-2020, by Type, in USD Million
Table Global Prescription Dermatological Drugs Market 2016-2020, by Type, in Volume
Figure Global Prescription Dermatological Drugs Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Prescription Dermatological Drugs Market Forecast 2021-2026, by Type, in USD Million
Table Global Prescription Dermatological Drugs Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Johnson & Johnson  (Company Profile, Sales Data etc.)
4.1.1 Johnson & Johnson  Profile
Table Johnson & Johnson  Overview List
4.1.2 Johnson & Johnson  Products & Services
4.1.3 Johnson & Johnson  Business Operation Conditions
Table Business Operation of Johnson & Johnson  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Merck  (Company Profile, Sales Data etc.)
4.2.1 Merck  Profile
Table Merck  Overview List
4.2.2 Merck  Products & Services
4.2.3 Merck  Business Operation Conditions
Table Business Operation of Merck  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Bayer  (Company Profile, Sales Data etc.)
4.3.1 Bayer  Profile
Table Bayer  Overview List
4.3.2 Bayer  Products & Services
4.3.3 Bayer  Business Operation Conditions
Table Business Operation of Bayer  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Mylan Pharmaceuticals  (Company Profile, Sales Data etc.)
4.4.1 Mylan Pharmaceuticals  Profile
Table Mylan Pharmaceuticals  Overview List
4.4.2 Mylan Pharmaceuticals  Products & Services
4.4.3 Mylan Pharmaceuticals  Business Operation Conditions
Table Business Operation of Mylan Pharmaceuticals  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Pfizer  (Company Profile, Sales Data etc.)
4.5.1 Pfizer  Profile
Table Pfizer  Overview List
4.5.2 Pfizer  Products & Services
4.5.3 Pfizer  Business Operation Conditions
Table Business Operation of Pfizer  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 F. Hoffmann-La Roche  (Company Profile, Sales Data etc.)
4.6.1 F. Hoffmann-La Roche  Profile
Table F. Hoffmann-La Roche  Overview List
4.6.2 F. Hoffmann-La Roche  Products & Services
4.6.3 F. Hoffmann-La Roche  Business Operation Conditions
Table Business Operation of F. Hoffmann-La Roche  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Allergan  (Company Profile, Sales Data etc.)
4.7.1 Allergan  Profile
Table Allergan  Overview List
4.7.2 Allergan  Products & Services
4.7.3 Allergan  Business Operation Conditions
Table Business Operation of Allergan  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Valeant Pharmaceuticals  (Company Profile, Sales Data etc.)
4.8.1 Valeant Pharmaceuticals  Profile
Table Valeant Pharmaceuticals  Overview List
4.8.2 Valeant Pharmaceuticals  Products & Services
4.8.3 Valeant Pharmaceuticals  Business Operation Conditions
Table Business Operation of Valeant Pharmaceuticals  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 PharmaDerm Pharmaceuticals  (Company Profile, Sales Data etc.)
4.9.1 PharmaDerm Pharmaceuticals  Profile
Table PharmaDerm Pharmaceuticals  Overview List
4.9.2 PharmaDerm Pharmaceuticals  Products & Services
4.9.3 PharmaDerm Pharmaceuticals  Business Operation Conditions
Table Business Operation of PharmaDerm Pharmaceuticals  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Allergan Inamed Corporation  (Company Profile, Sales Data etc.)
4.10.1 Allergan Inamed Corporation  Profile
Table Allergan Inamed Corporation  Overview List
4.10.2 Allergan Inamed Corporation  Products & Services
4.10.3 Allergan Inamed Corporation  Business Operation Conditions
Table Business Operation of Allergan Inamed Corporation  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Prescription Dermatological Drugs Sales Revenue 2016-2020, by Company, in USD Million
Table Global Prescription Dermatological Drugs Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Prescription Dermatological Drugs Sales Revenue Share in 2020, by Company, in USD Million
Table Global Prescription Dermatological Drugs Sales Volume 2016-2020, by Company, in Volume
Table Global Prescription Dermatological Drugs Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Prescription Dermatological Drugs Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Prescription Dermatological Drugs Market Concentration, in 2020
Figure Europe Prescription Dermatological Drugs Market Market Concentration, in 2020
Figure Asia-Pacific Prescription Dermatological Drugs MMarket Concentration, in 2020
Figure South America Prescription Dermatological Drugs Market Concentration, in 2020
Figure Middle East & Africa Prescription Dermatological Drugs Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospital Pharmacies 
Figure Prescription Dermatological Drugs Demand in Hospital Pharmacies , 2016-2020, in USD Million
Figure Prescription Dermatological Drugs Demand in Hospital Pharmacies , 2016-2020, in Volume
6.1.2 Demand in Retail Pharmacies 
Figure Prescription Dermatological Drugs Demand in Retail Pharmacies , 2016-2020, in USD Million
Figure Prescription Dermatological Drugs Demand in Retail Pharmacies , 2016-2020, in Volume
6.1.3 Demand in Online Pharmacies
Figure Prescription Dermatological Drugs Demand in Online Pharmacies, 2016-2020, in USD Million
Figure Prescription Dermatological Drugs Demand in Online Pharmacies, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Prescription Dermatological Drugs Demand Forecast 2021-2026, by Application, in USD Million
Figure Prescription Dermatological Drugs Market Growth 2021-2026, by Application, in USD Million
Figure Prescription Dermatological Drugs Market Share in 2026, by Application, in USD Million
Table Prescription Dermatological Drugs Demand Forecast 2021-2026, by Application, in Volume
Table Prescription Dermatological Drugs Market Growth 2021-2026, by Application, in Volume
Table Prescription Dermatological Drugs Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Prescription Dermatological Drugs Production 2016-2020, by Region, in USD Million
Table Prescription Dermatological Drugs Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Prescription Dermatological Drugs Market 2016-2020, by Region, in USD Million
Table Global Prescription Dermatological Drugs Market Share 2016-2020, by Region, in USD Million
Table Global Prescription Dermatological Drugs Market 2016-2020, by Region, in Volume
Table Global Prescription Dermatological Drugs Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Prescription Dermatological Drugs Market Size and Growth 2016-2020, in USD Million
Figure North America Prescription Dermatological Drugs Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Prescription Dermatological Drugs Market Size 2016-2020, by Country, in USD Million
Table North America Prescription Dermatological Drugs Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Prescription Dermatological Drugs Market Size and Growth 2016-2020, in USD Million
Figure Europe Prescription Dermatological Drugs Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Prescription Dermatological Drugs Market Size 2016-2020, by Country, in USD Million
Table Europe Prescription Dermatological Drugs Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Prescription Dermatological Drugs Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Prescription Dermatological Drugs Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Prescription Dermatological Drugs Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Prescription Dermatological Drugs Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Prescription Dermatological Drugs Market Size and Growth 2016-2020, in USD Million
Figure South America Prescription Dermatological Drugs Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Prescription Dermatological Drugs Market Size 2016-2020, by Country, in USD Million
Table South America Prescription Dermatological Drugs Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Prescription Dermatological Drugs Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Prescription Dermatological Drugs Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Prescription Dermatological Drugs Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Prescription Dermatological Drugs Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Prescription Dermatological Drugs Market Forecast 2021-2026, by Region, in USD Million
Table Prescription Dermatological Drugs Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion

List of Figure

List of Table
List of Table
1. Table Upstream Segment of Prescription Dermatological Drugs
2. Table Application Segment of Prescription Dermatological Drugs
3. Table Global Prescription Dermatological Drugs Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Anti-aging Drugs 
5. Table Major Company List of Dermatitis Drugs 
6. Table Major Company List of Hair Loss Drugs 
7. Table Major Company List of Psoriasis Drugs 
8. Table Major Company List of Skin Cancer Drugs 
9. Table Major Company List of Melasma Drugs 
10. Table Major Company List of Seborrhea Drugs
11. Table Global Prescription Dermatological Drugs Market 2016-2020, by Type, in USD Million
12. Table Global Prescription Dermatological Drugs Market 2016-2020, by Type, in Volume
13. Table Global Prescription Dermatological Drugs Market Forecast 2021-2026, by Type, in USD Million
14. Table Global Prescription Dermatological Drugs Market Forecast 2021-2026, by Type, in Volume
15. Table Johnson & Johnson  Overview List
16. Table Business Operation of Johnson & Johnson  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
17. Table Merck  Overview List
18. Table Business Operation of Merck  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
19. Table Bayer  Overview List
20. Table Business Operation of Bayer  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
21. Table Mylan Pharmaceuticals  Overview List
22. Table Business Operation of Mylan Pharmaceuticals  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
23. Table Pfizer  Overview List
24. Table Business Operation of Pfizer  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
25. Table F. Hoffmann-La Roche  Overview List
26. Table Business Operation of F. Hoffmann-La Roche  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
27. Table Allergan  Overview List
28. Table Business Operation of Allergan  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
29. Table Valeant Pharmaceuticals  Overview List
30. Table Business Operation of Valeant Pharmaceuticals  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
31. Table PharmaDerm Pharmaceuticals  Overview List
32. Table Business Operation of PharmaDerm Pharmaceuticals  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
33. Table Allergan Inamed Corporation  Overview List
34. Table Business Operation of Allergan Inamed Corporation  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
35. Table Global Prescription Dermatological Drugs Sales Revenue 2016-2020, by Company, in USD Million
36. Table Global Prescription Dermatological Drugs Sales Revenue Share 2016-2020, by Company, in USD Million
37. Table Global Prescription Dermatological Drugs Sales Volume 2016-2020, by Company, in Volume
38. Table Global Prescription Dermatological Drugs Sales Volume Share 2016-2020, by Company, in Volume
39. Table Regional Demand Comparison List
40. Table Major Application in Different Regions
41. Table Prescription Dermatological Drugs Demand Forecast 2021-2026, by Application, in USD Million
42. Table Prescription Dermatological Drugs Demand Forecast 2021-2026, by Application, in Volume
43. Table Prescription Dermatological Drugs Market Growth 2021-2026, by Application, in Volume
44. Table Prescription Dermatological Drugs Market Share in 2026, by Application, in Volume
45. Table Prescription Dermatological Drugs Production 2016-2020, by Region, in USD Million
46. Table Prescription Dermatological Drugs Production 2016-2020, by Region, in Volume
47. Table Global Prescription Dermatological Drugs Market 2016-2020, by Region, in USD Million
48. Table Global Prescription Dermatological Drugs Market Share 2016-2020, by Region, in USD Million
49. Table Global Prescription Dermatological Drugs Market 2016-2020, by Region, in Volume
50. Table Global Prescription Dermatological Drugs Market Share 2016-2020, by Region, in Volume
51. Table North America Prescription Dermatological Drugs Market Size 2016-2020, by Country, in USD Million
52. Table North America Prescription Dermatological Drugs Market Size 2016-2020, by Country, in Volume
53. Table Europe Prescription Dermatological Drugs Market Size 2016-2020, by Country, in USD Million
54. Table Europe Prescription Dermatological Drugs Market Size 2016-2020, by Country, in Volume
55. Table Asia-Pacific Prescription Dermatological Drugs Market Size 2016-2020, by Country, in USD Million
56. Table Asia-Pacific Prescription Dermatological Drugs Market Size 2016-2020, by Country, in Volume
57. Table South America Prescription Dermatological Drugs Market Size 2016-2020, by Country, in USD Million
58. Table South America Prescription Dermatological Drugs Market Size 2016-2020, by Country, in Volume
59. Table Middle East & Africa Prescription Dermatological Drugs Market Size 2016-2020, by Country, in USD Million
60. Table Middle East & Africa Prescription Dermatological Drugs Market Size 2016-2020, by Country, in Volume
61. Table Prescription Dermatological Drugs Market Forecast 2021-2026, by Region, in USD Million
62. Table Prescription Dermatological Drugs Market Forecast 2021-2026, by Region, in Volume
63. Table Price Factors List